Prevail Therapeutics Employee Directory
Biotechnology ResearchNew York, United States11-50 Employees
Prevail Therapeutics is a biotechnology company focused on developing gene therapies that target the genetic roots of Parkinson’s disease and other neurodegenerative disorders. The company seeks to translate advances in human genetics and gene therapy into medicines that slow or stop disease progression, focusing on patient populations with urgent unmet needs where therapies that modify the course of disease are not yet available. Founded in 2017 and based in New York City, New York, Prevail operates from the Alexandria Center for Life Science and has been a wholly owned subsidiary of Eli Lilly and Company since January 2021. Within the biotechnology research landscape, Prevail concentrates on central nervous system conditions and aims to bring therapies that modify disease progression to patients who lack current options. The company has engaged in external collaborations to advance its programs, including partnerships with other biotech firms to explore in vivo gene therapies and non-invasive delivery approaches for CNS diseases.
1-888-653-2347 
support@leadiq.com 
